PRF Technologies Files F-1 for Resale of Shares Under New $15M Highly Dilutive Equity Line

summarizeSummary

PRF Technologies has registered shares for resale under a new $15.0 million dilutive equity line, which could result in over 240% dilution to existing shareholders and signals an ongoing reliance on unfavorable financing terms.

check_boxKey Events · Financing and Capital Events · PRFX

• New $15.0 Million Equity Line Agreement

  The company entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. on June 18, 2026, allowing it to sell up to $15.0 million in ordinary shares over 36 months.

• Significant Share Registration for Resale

  This F-1 registers 7,500,000 ordinary shares for resale by YA, comprising 20,276 commitment shares and 7,479,724 advance shares that may be issued for cash.

• Extreme Potential Dilution

  If all 7,479,724 advance shares are issued, it would represent approximately 246% dilution to the 3,041,830 ordinary shares currently outstanding.

• Discounted Share Pricing

  Shares will be purchased by YA at 97% of the lowest of the three daily volume-weighted average prices (VWAPs) during a pricing period, indicating a discount to market.

auto_awesomeAnalysis · PRFX · Life Sciences

PRF Technologies has filed an F-1 registration statement for the resale of up to 7,500,000 ordinary shares by YA II PN, LTD. This relates to a new Standby Equity Purchase Agreement (SEPA) dated June 18, 2026, under which the company may sell up to $15.0 million in shares to YA. This agreement replaces a recently terminated $10.0 million SEPA, indicating a continuous and substantial need for capital. The potential issuance of 7,479,724 new shares for cash represents an approximate 246% dilution to current shareholders, significantly exceeding the company's current market capitalization. The shares will be sold at a discount to market prices, highlighting the unfavorable terms necessary to secure this financing and the severe dilutive impact on existing equity.